InvestorsHub Logo
Followers 199
Posts 17208
Boards Moderated 2
Alias Born 02/17/2012

Re: None

Monday, 11/06/2023 8:13:42 AM

Monday, November 06, 2023 8:13:42 AM

Post# of 5634
AAV-Based Strategies for Treatment of Retinal and Choroidal Vascular Diseases: Advances in Age-Related Macular Degeneration and Diabetic Retinopathy Therapies

“Christopher J. Layton owns shares in Ocugene, a gene therapy company. Jason C. Steel has been a consultant for Ocugene and owns intellectual property in breast cancer gene therapy.”

https://link.springer.com/article/10.1007/s40259-023-00629-y
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent OCGN News